Mark F. Kubik

Corporate Officer/Principal presso GENOR BIOPHARMA HOLDINGS LIMITED

60 anni

Health Technology

Consumer Services

Posizioni attive di Mark F. Kubik

Società	Posizione	Inizio	Fine
GENOR BIOPHARMA HOLDINGS LIMITED	Corporate Officer/Principal	17/08/2021	-

Società	Posizione	Inizio	Fine
OncoImmune, Inc. OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD.	Corporate Officer/Principal	-	-
MERCK & CO., INC.	Corporate Officer/Principal	-	-
ACTINIUM PHARMACEUTICALS, INC.	Corporate Officer/Principal	03/03/2021	-

The Leeds School of Business	Masters Business Admin
University of Colorado Boulder	Undergraduate Degree

Distribuzione geografica

Stati Uniti	6
Isole Cayman	2

Posizioni

Corporate Officer/Principal	4
Masters Business Admin	1
Undergraduate Degree	1

Settori

Health Technology	5
Consumer Services	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
ACTINIUM PHARMACEUTICALS, INC.	Health Technology
GENOR BIOPHARMA HOLDINGS LIMITED	Health Technology
MERCK & CO., INC.	Health Technology

Aziende private	1
OncoImmune, Inc. OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD.	Health Technology

Aziende private

Health Technology